Navigation Links
Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents at One Year Compared to Bare-Metal Stents in Diabetic Patients Experiencing Heart Attack
Date:3/15/2010

ed with the TAXUS Express Stent when compared to bare-metal stents," said Keith Dawkins, M.D., Senior Vice President and Chief Medical Officer for Boston Scientific.  "The data also showed comparable safety outcomes for TAXUS Express and bare-metal stents in diabetic patients.  This study provides important data to physicians regarding the use of drug-eluting stents in high-risk AMI patients, especially those with diabetes, during the early hours of a heart attack.  We are proud to support this and other large clinical trials that provide the medical community data that can be used in combination with broader clinical judgment to develop optimal treatment strategies for challenging patient subsets."

HORIZONS AMI results demonstrated that the TAXUS Express Stent significantly reduced ischemia-driven TLR compared to the bare-metal control stent (BMS) in both diabetic patients (5.2% vs. 11.2%, p=0.03, a 54 percent reduction), and non-diabetic patients (4.3% vs. 6.8%, p=0.02, a 37 percent reduction).  Binary in-stent restenosis at 13 months was also significantly reduced for diabetic patients treated with the TAXUS Express Stent compared to BMS (8.2% vs. 43.9%, p<0.0001, an 81 percent reduction).  Additionally, mean angiographic late loss at 13 months was significantly reduced for diabetic patients treated with the TAXUS Express Stent compared to BMS (0.38 mm vs. 1.13 mm, p<0.0001, a 66 percent reduction).

The primary safety measure of major adverse cardiac events (MACE) at one year was compar
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 5, 2015 Faced with fast economy and population ... China,s medical device industry has been ... largest demands have been Beijing , ... other first-tier cities. However, the entry of a large number ... "high-end" markets in first-tier cities increasingly saturated. How do medical ...
(Date:5/5/2015)... , May 05, 2015 Research and ... the addition of the "Clinical Laboratory,Molecular Diagnostics ... 2015 to 2019 - Latin America, Africa and ... A market that just keeps on ... benefit from the explosion in biotechnology, especially genomics. ...
(Date:5/5/2015)... Colo. , May 5, 2015  As cannabis prohibition ends one state at a time, more cannabis entrepreneurs are coming ... the idea phase, and the primary reason is lack of funding. ... ... ... ...
Breaking Medicine Technology:MEDITEXPO JIANGSU 2015 is to Help Medical Device Companies Explore Business Opportunities in Wider Markets 2MEDITEXPO JIANGSU 2015 is to Help Medical Device Companies Explore Business Opportunities in Wider Markets 3MEDITEXPO JIANGSU 2015 is to Help Medical Device Companies Explore Business Opportunities in Wider Markets 4Latin America, Africa and Middle East Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market 2015-2019 2Top Ten Ways Cannabis Startups are Getting Funded 2Top Ten Ways Cannabis Startups are Getting Funded 3Top Ten Ways Cannabis Startups are Getting Funded 4
... Astellas Pharma Inc. (Tokyo:4503, "Astellas") announced today that ... 1] , which will further reinforce the company,s commitment to ... world. "We are committed to adopting the Global ... culture and day-to-day operations of our company and through Astellas, ...
... 2011 Watson Pharmaceuticals, Inc. (NYSE: WPI ... filed an Abbreviated New Drug Application (ANDA) with the ... market rivastigmine transdermal system patches, 4.6 mg/24 hr and ... a generic version of Novartis, Exelon(R) Patch. Exelon(R) is ...
Cached Medicine Technology:Astellas Signs United Nations Global Compact 2Astellas Signs United Nations Global Compact 3Watson Confirms Exelon(R) Patent Challenge 2Watson Confirms Exelon(R) Patent Challenge 3
(Date:5/5/2015)... AZ (PRWEB) May 05, 2015 NCPDP ... Elite Partner Program. The program establishes a three-year commitment ... a maximum of 10 Elite Partners. “AmerisourceBergen has supported ... Stember, President of NCPDP, “and this is a wonderful ... , We can trace AmerisourceBergen back to our ...
(Date:5/5/2015)... Leveraging the industry-leading technology found at ... experienced team of fertility specialists are committed to the ... the globe. , “We’re honored that Maternity Health IVF ... global leader in reproductive medicine. The clinic offers some ... the world who play an important role in the ...
(Date:5/5/2015)... York (PRWEB) May 05, 2015 ... http://www.testosteronelawsuithub.com/ ) filed on behalf of men ... to their use of prescription testosterone replacement ... federal multidistrict litigation underway in U.S. District ... court documents dated May 1st, defendants AbbVie, ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 Baptist Medical ... Commission on Cancer (CoC) of the American College of ... program must meet more than 30 Commission on Cancer ... a survey process, and maintain levels of excellence in ... When patients choose to seek care locally at a ...
(Date:5/5/2015)... Georgia (PRWEB) May 05, 2015 ... of Victoria BC announced the Skedans Sensor Collaboration ... platform, for mobile and web app developers, provides tooling ... airborne and mobile sensors. , The Skedans Sensor Collaboration ... the intersection of the Internet of Things, Web Real ...
Breaking Medicine News(10 mins):Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 2Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 3Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 2Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 3Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 3Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 4Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 2Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 3Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 4Health News:Skedans Systems Announces Skedans Sensor Collaboration Platform at AUVSI's Unmanned Systems 2015 in Atlanta 2
... could lead to new drugs in fight against obesity, study ... produced in the brain may play a role in regulating ... new study. , For the study, researchers looked at ... genetic condition that occurs in one in 500,000 to a ...
... to standard drug therapy prolonged survival, study finds , , ... myeloma who could not tolerate high dose chemotherapy lived ... standard treatment, a new study found. , The finding ... plasma cells, a chronic rather than a lethal disease. ...
... form of the eye disease , , WEDNESDAY, Aug. 27 ... China have identified the first gene directly associated with ... two forms of age-related macular degeneration that currently threatens ... , The discovery, based on work with both human ...
... COLUMBUS, Ga., Aug. 27 Aflac Incorporated,(NYSE: AFL ... at the Keefe,Bruyette & Woods 2008 Insurance Conference. President ... Incorporated, and he is,scheduled to make a presentation on ... Incorporated presentation, Mr. Cloninger will discuss the,company,s outlook for ...
... with unlawful changes in wages and benefits, HEMET, Calif., ... Monday issued a complaint against the,board of directors of Valley ... that the board had already voted to agree to., ... not for the money," said,Lisa Howell, a registered nurse at ...
... or not,women and men have different oral health needs. ... throughout their life, including,puberty, pregnancy and menopause., The ... evolving oral health needs will ensure that everyone,regardless of ... health care they,need to maintain healthy teeth and gums., ...
Cached Medicine News:Health News:Low Levels of Brain Chemical May Control Appetite 2Health News:Combination Therapy Helps to Combat Myeloma 2Health News:Combination Therapy Helps to Combat Myeloma 3Health News:Gene Linked to 'Dry' Macular Degeneration 2Health News:Gene Linked to 'Dry' Macular Degeneration 3Health News:Aflac Incorporated To Present at the Keefe, Bruyette & Woods 2008 Insurance Conference 2Health News:State Board Issues Complaint: VHS Board Should Have Signed Contract With Caregivers 2Health News:What You Need to Know About Women's Oral Health 2
... The U.S. Food and Drug Administration ... ReSTOR intraocular lens (IOL) for cataract patients ... uses a revolutionary apodized diffractive technology to ... vision (near, intermediate and distance) that greatly ...
... for quality vision with ACRYSOF IQ IOL. ... aberration by addressing the effects of over-refraction ... increasing edge thickness. Human corneal characteristics ... provides improved image quality.,MTF (measured in the ...
... find the samaritan AED easy to ... and rescue professionals) will appreciate the ... override, and the ECG monitoring availability ... is an exceptionally well-engineered, lightweight (4lbs), ...
... The Brilliance 64-channel configuration breaks through ... large volume, thin-slice coverage to improve ... , ,With 40mm of thin-slice coverage, ... imaging, allowing for unprecedented coronary artery ...
Medicine Products: